Azacitidine Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Azacitidine Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Dec 18, 2020. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-771-39
Dosage Form
Injection
Presentation
Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)
Initial Posting
Dec 18, 2020

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.